Invention Grant
US08551490B2 Genetic products differentially expressed in tumors and use thereof
有权
在肿瘤中差异表达的遗传产物及其用途
- Patent Title: Genetic products differentially expressed in tumors and use thereof
- Patent Title (中): 在肿瘤中差异表达的遗传产物及其用途
-
Application No.: US13184719Application Date: 2011-07-18
-
Publication No.: US08551490B2Publication Date: 2013-10-08
- Inventor: Ugur Sahin , Özlem Türeci , Michael Koslowski
- Applicant: Ugur Sahin , Özlem Türeci , Michael Koslowski
- Applicant Address: DE Mainz
- Assignee: Ganymed Pharmaceuticals AG
- Current Assignee: Ganymed Pharmaceuticals AG
- Current Assignee Address: DE Mainz
- Agency: McAndrews, Held & Malloy Ltd.
- Priority: DE102-11-088 20020313
- Main IPC: A61K39/00
- IPC: A61K39/00
Abstract:
The invention relates to the identification of genetic products that are expressed in association with a tumor and the nucleic acid coding therefor. The invention relates to the therapy and diagnosis of diseases in which the genetic products that are expressed in association with a tumor are expressed in an aberrant manner. The invention also relates to proteins, polypeptides, and peptides which are expressed in association with a tumor and the nucleic acids coding therefor.
Public/Granted literature
- US20120014948A1 GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND USE THEREOF Public/Granted day:2012-01-19
Information query
